Remove 2016 Remove Ethics Remove Safety
article thumbnail

Staying abreast of regulations with NGS?based viral safety for faster, safer and more ethical lot release of our vaccines

European Pharmaceutical Review

How does that impact the safety of the biologics? Safety is key to the development of any medicine, but the safety considerations linked to bioproduction are more complex because biologics are more sophisticated medicines than small molecules. London: European Medicines Agency; 2016 [cited May 2022]. References.

Ethics 98
article thumbnail

New Bill could enhance UK clinical trial regulation

European Pharmaceutical Review

Benefits of The Future Clinical Trials Bill Chiefly, the Bill’s goal is to increase patient participation and overall, ensure clinical trials have the highest levels of safety while enabling greater regulatory pragmatism, the author explained. This is according to a 2016 paper published in Clinical and Translational Oncology.

Ethics 105
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Improving Access to Medicine: The Role of Pharma Companies in Emerging Markets

PM360

As shareholders and consumers demand greater transparency, accountability, and ethical behavior from corporations, pharmaceutical companies are expected to play a role in addressing these issues. This is also relevant as, in recent years, environmental and social issues have become increasingly important for companies.

article thumbnail

The Use of Big Data in Pharmaceutical Marketing: Opportunities and Challenges

Pharma Marketing Network

Additionally, by analyzing data from completed clinical trials, companies can gain insights into the safety and effectiveness of their products, which can inform the development of new drugs. Additionally, companies must ensure that the data they collect is accurate and reliable, and that it is used ethically and responsibly.

article thumbnail

The Use of Big Data in Pharmaceutical Marketing: Opportunities and Challenges

Pharma Marketing Network

Additionally, by analyzing data from completed clinical trials, companies can gain insights into the safety and effectiveness of their products, which can inform the development of new drugs. Additionally, companies must ensure that the data they collect is accurate and reliable, and that it is used ethically and responsibly.

article thumbnail

Cyberwarfare: A Healthcare Marketers’ Guide in the Fight for Corporate Reputation

PM360

Combined, they are having a lasting effect on the reputation of the healthcare sector and the safety and durability of its products and services. The ethical standard of putting patients first urges a more prompt and immediate disclosure. Hospitals, Clinics, and Other Health Care Delivery Organizations, 2016-2021.” 2022.4873.

article thumbnail

The Traditional Pharma Model Isn’t Working – It’s Time to Evolve!

PharmaKinnex

The pharmaceutical industry of 2022 is very different from the space that we all knew in 2012, 2016, or even 2020. More convenience and safety? The Traditional Pharma Model Isn’t Working – It’s Time to Evolve! August 23, 2022. dstansberry@costellocreativegroup.com. What’s not to love?

Pharma 52